ATTORNEY ADVERTISING. PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME.
MILBERG LLP > Actos Investigation

Actos Investigation

Free Actos Claim Evaluation

  3. (required)
  4. (required)
  6. (required)
  7. (valid email required)
 


The submission of information to Milberg LLP or one of its attorneys does not create, and the receipt of it does not constitute, an attorney-client relationship. This website presents general information about, among other things, Milberg LLP, currently pending lawsuits, and on-going investigations, which is not intended to be legal advice, nor should you consider it as such. Please do not send confidential or sensitive information and/or documents to anyone at the Firm until you have been notified that a formal attorney-client relationship has been established. Contacting Milberg LLP does not, and should not, limit you in any way from seeking legal advice regarding this or any other matter. By submitting this form, you agree that Milberg LLP may contact you about this or other potential matters of interest to investors and consumers.


*Denotes required field

FREE CLAIM EVALUATION
CONTACT US AT (866) 350-9342

Manufactured by Takeda Pharmaceuticals, Actos was approved in 1999 to help lower blood sugar levels in patients with type 2 diabetes.  Actos sales soared as high as $4.3 million after 2007, when competing drug Avandia was found to increase risk of heart attack.  Unfortunately, Actos’ safety is now in question, as research emerges linking the diabetes drug to a 40 percent increased risk of bladder cancer.

Actos Linked to Bladder Cancer Risk

In June 2011, the Food and Drug Administration (FDA) mandated a label change for Actos regarding its link to bladder cancer.  This announcement is based on the FDA’s review of an ongoing, 10-year study measuring the safety of Actos.  The study has found that those who take Actos for more than one year or at the highest cumulative dose are 40 percent more likely to develop bladder cancer.

European Countries Take Action Against Actos

In its Actos safety announcement, the FDA noted a cohort study conducted in France that also found an increased risk for bladder cancer associated with Actos use.  This study has led the French Medicines Agency to suspend the use of Actos in France until further research is available.  Based on the French study, Germany’s Federal Institute of Drugs and Medical Devices has disallowed new prescriptions of Actos until further notice.

Actos Lawsuits

Lawsuits have already been filed against Takeda Pharmaceuticals by Actos victims claiming that use of the diabetes drug caused them to develop bladder cancer.  Legal experts predict that lawsuits could number in the thousands.  If a person has been diagnosed with bladder cancer after taking Actos, he or she deserves compensation for the associated physical damages, financial burdens and emotional suffering.  If you believe your loved one’s death from bladder cancer may have been caused by Actos use, you and your family also may file for compensation for your devastating loss.

Symptoms of bladder cancer may include:

  • Abdominal pain
  • Bloody urine
  • Painful urination
  • Urinary frequency
  • Urinary urgency
  • Urine leakage
  • Bone pain or tenderness
  • Weight loss
  • Fatigue

If you or a loved one has experienced symptoms of bladder cancer or has been diagnosed with it, or if you have legal concerns related to Actos, please contact us for a Free Claim Evaluation by calling (866) 350-9342.  You may be legally entitled to recover medical expenses and lost earnings, as well as receive compensation for physical pain and suffering, mental anguish and physical impairment.  For persons who have died, their surviving spouse or other family members often can file a wrongful death action.

Milberg LLP
One Pennsylvania Plaza, 49th Fl.
New York, NY, 10119-0165
Phone number: (866) 350-9342

Attorney Advertising.
Prior Results Do Not Guarantee A Similar Outcome.

© 2012 Milberg LLP  |  ATTORNEY ADVERTISING. PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME.